- Negative pregnancy test in women of childbearing potential (WOCBP) within 30 days of Durvalumab administration or evidence of post-menopausal status. Women will be considered post-menopausal if they have been amenorrheic for 12 months without an alternative medical cause or underwent surgical sterilization (bilateral oophorectomy or hysterectomy)